About ThermoGenesis Corp.
ThermoGenesis Corp. (http://www.thermogenesis.com) is a leader in
developing and manufacturing automated blood processing systems and
disposable products that enable the manufacture, preservation and delivery
of cell and tissue therapy products. These products include:
-- The BioArchive(R) System, an automated cryogenic device, is used by
cord blood stem cell banks in more than 25 countries for
cryopreserving and archiving cord blood stem cell units for
transplant. GE Healthcare is the non-exclusive global distribution
partner for the BioArchive System.
-- AXP(TM) AutoXpress Platform (AXP(TM)) is a proprietary family of
automated devices that includes the AXP and the MarrowXpress(TM) and
companion sterile blood processing disposable for harvesting stem
cells in a closed system. The AXP device is used for the processing of
cord blood. GE Healthcare is the exclusive global distribution
partner for the AXP cord blood product. The MarrowXpress is used for
isolating stem cells from bone marrow. ThermoGenesis sells the
MarrowXpress directly to global customers.
-- The CryoSeal(R) FS System, an automated device and companion sterile
blood processing disposable, is used to prepare fibrin sealants from
plasma in about an hour. We received FDA approval to market the
CryoSeal FS System in liver resection surgeries in July 2007. The
CryoSeal FS System has received the CE-Mark. From a marketing
perspective, the CE Mark is the European equivalent to an FDA
approval, in that it allows sales of the product throughout the
European community. Asahi Medical is the exclusive distributor for the
CryoSeal System in Japan and the Company markets through independent
|SOURCE ThermoGenesis Corp.|
Copyright©2008 PR Newswire.
All rights reserved